Furui Tatsuro, Takai Yasushi, Kimura Fuminori, Kitajima Michio, Nakatsuka Mikiya, Morishige Ken-Ichiro, Higuchi Akiko, Shimizu Chikako, Ozawa Miwa, Ohara Akira, Tatara Ryohei, Nakamura Terukazu, Horibe Keizo, Suzuki Nao
Department of Obstetrics and Gynecology Gifu University Graduate School of Medicine Gifu Japan.
Department of Obstetrics and Gynecology, Saitama Medical Center Saitama Medical University Kawagoe Japan.
Reprod Med Biol. 2018 Nov 20;18(1):97-104. doi: 10.1002/rmb2.12256. eCollection 2019 Jan.
This study evaluated the current status of reproductive disorders and provision of information on oncofertility to female adolescent and young adult (AYA) cancer patients in Japan.
A national survey of AYA cancer survivors was conducted. Children were <15 years old, and AYAs were 15-39 years old. Results from the survivors of other than gynecological disease who underwent chemotherapy were analyzed.
Among the survivors, 41.4% were concerned about their reproductive function and infertility, and 36.2% were aware of menstrual cycle abnormalities. Among them, 15.5% (n = 20) of all and 21.2% (n = 17) of the AYA-onset survivors suffered infertility due to chemo- or radiotherapy and gave up childbearing. These rates were significantly higher than those of healthy AYAs. Although 80.8% of AYA-onset survivors answered that they had received information on reproductive function and infertility, only 55.8% had received information on fertility preservation methods. Furthermore, only 22.4% of all and 42.3% of AYA-onset survivors had received pretreatment information on fertility preservation methods.
Not a few AYA cancer survivors reported reproductive dysfunction. These findings indicate that information provided on therapy-related problems before cancer treatment in Japan was insufficient and highlight the need to improve patient decision-making and support systems for fertility preservation.
本研究评估了日本女性青少年及年轻成人(AYA)癌症患者的生殖系统疾病现状以及关于肿瘤生育力的信息提供情况。
对AYA癌症幸存者进行了一项全国性调查。儿童年龄小于15岁,AYA年龄为15 - 39岁。分析了接受化疗的非妇科疾病幸存者的结果。
在幸存者中,41.4%的人担心自己的生殖功能和不孕问题,36.2%的人意识到月经周期异常。其中,所有幸存者中有15.5%(n = 20)以及AYA发病的幸存者中有21.2%(n = 17)因化疗或放疗导致不孕并放弃生育。这些比率显著高于健康的AYA人群。尽管80.8%的AYA发病幸存者回答他们收到了关于生殖功能和不孕的信息,但只有55.8%的人收到了关于生育力保存方法的信息。此外,所有幸存者中只有22.4%以及AYA发病的幸存者中有42.3%在治疗前收到了关于生育力保存方法的信息。
不少AYA癌症幸存者报告存在生殖功能障碍。这些发现表明,日本在癌症治疗前提供的与治疗相关问题的信息不足,并突出了改善患者决策和生育力保存支持系统的必要性。